Dr. Daniel G. Bamira, MD

Dr. Bamira practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Bamira's NPI, 1689952764, was assigned on July 24, 2011. Dr. Bamira holds New York license 288342.

Dr. Bamira's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Bamira's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Bamira is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Bamira to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bamira practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bamira's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bamira is licensed in New York.

CMS data shows 1,748 Medicare services from Dr. Bamira across 12 procedure codes in 2024, for 952 Medicare patients. Medicare paid $73,513 for them.

CMS counts 952 Medicare patients who saw Dr. Bamira in 2024. The largest group is 75 to 84, with 359 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bamira's median patient age at 62, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bamira for performance year 2024, reported as part of a group. Dr. Bamira accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Bamira, published from 2011 to 2024. 2023 was the busiest year, with 6. The most frequent topics are Echocardiography, Transesophageal, Echocardiography, Three-Dimensional and Mitral Valve. Dr. Bamira has published most often in CASE (Phila). Dr. Bamira's most frequent co-authors are Larry A. Chinitz, MD, Anthony Aizer, MD and Cezar S. Staniloae, MD.

Dmand AI links Dr. Bamira to 1 clinical trial. Conditions studied include Tricuspid Valve Insufficiency and Gastroesophageal Reflux.

CMS Open Payments shows 8 general payments to Dr. Bamira from 2 drug and device companies from 2023 to 2024. Device or supply loans make up the largest share, 53% of the total. Abbott Laboratories paid the most, $484.